// Science · Glossary

CBDV

⚗️ Science First mentioned: Ep. 017

Cannabidivarin — a minor cannabinoid structurally related to CBD that is beginning to appear in advanced laboratory testing at trace levels (around 0.25%). Early observations suggest CBDV may have specific action against convulsions. Its presence in whole-plant cannabis extracts but absence in hemp-derived CBD isolates may help explain why cannabis-derived CBD often outperforms hemp CBD therapeutically — the trace CBDV and other minor cannabinoids contribute to the overall effect.

CBDV was first mentioned in Episode 17 when Johnny B reported Humboldt County lab panels detecting it as an anomaly in CBD-rich strains at approximately 0.25%. The discussion raised an important question: if whole-plant cannabis CBD consistently outperforms isolated hemp CBD in patient reports, could trace amounts of CBDV and other minor cannabinoids be the reason? This supports the entourage effect thesis — that the therapeutic value of cannabis comes from the full spectrum of compounds working together, not from any single isolated molecule. CBDV research is still in early stages but its detection in routine lab testing suggests it may be more significant than its trace presence implies.

Ep. 017 Hash Church XVII